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Abstract As yet, the physiological significance of hydroxyla-
tion of anandamide and linoleoyl amides is unknown. Therefore, 
we investigated whether hydroxylation of ODNHEtOH and 
ODNH2 influences their binding abilities to the CB-1 receptor 
and whether it alters their reactivity towards a fatty acid amide 
hydrolase (FAAH) from rat brain. Neither the fatty acid amides 
nor their hydroxylated derivatives were able to displace the 
potent cannabinoid |3H]CP 55.940 from the CB-1 receptor 
(Äi> 1 u.M). Hydroxylation of ODNHEtOH resulted in a 
strong reduction of the maximum rate of hydrolysis by a FAAH, 
but the affinity of FAAH for the substrate remained of the same 
order of magnitude. Hydroxylation of ODNH2 led to a decrease 
in the affinity of FAAH for the substrate, but its maximum rate 
of conversion was unaffected. Furthermore, hydroxylation of 
ODNHEtOH enhanced its capacity to inhibit competitively the 
hydrolysis of anandamide. The resulting prolonged lifetime of 
anandamide and other fatty acid amide derivatives may have a 
considerable impact on cellular signal transduction. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Fatty acid amides constitute a new class of neuro- and 
immunoregulatory molecules [1]. Anandamide (arachidonyl 
ethanolamide) binds to the cannabinoid binding receptor 1 
(CB-1), which is coupled to Grproteins [2]. As a consequence, 
several cellular signaling responses are induced, such as inhib-
ition of adenylate cyclase [3] and of N-type Ca2+ channels [4]. 
In addition, palmitoyl ethanolamide binds to the CB-2 recep-
tor and down-regulates mast cell activation [5]. Acyl ethanol-
*Corresponding author. Fax: (39) (6) 72596468. 
Abbreviations: BSA, bovine serum albumin; CB-1/2, cannabinoid 
binding receptor-1/2; FAAH, fatty acid amide hydrolase; 12/15-
HETE, 12/15-hydroxyeicosatetraenoic acid; 13-HODNHEtOH, 13-
(5')-hydroxy-9Z,ll£ ,-octadeca-9,ll-dienoyl ethanolamide; 13-
HODNH2 , 13-(S)-hydroxy-9Z,ll£-octadeca-9,ll-dienoyl amide; 
LCS, liquid scintillation cocktail; ODNHEtOH, 9Z,12Z-octadeca-
9,12-dienoyl ethanolamide; ODNH2, 9Z,12Z-octadeca-9,12-dienoyl 
amide; PEI, polyethylene imine; PMSF, phenylmethylsulfonyl fluo-
ride; RP-HPLC, reversed phase high performance liquid chromatog-
raphy; TLC, thin layer chromatography 
amides, including linoleoyl ethanolamide, can be formed 
through enzymatic hydrolysis of the corresponding acyl phos-
phatidyl ethanolamides by phospolipase D [6]. 
Cellular concentrations of neuroregulatory molecules, like 
anandamide, are strictly regulated. Indeed, anandamide and 
other fatty acid amides have been reported to be rapidly de-
graded by a fatty acid amide hydrolase (FAAH). Recently, 
Cravatt et al. have isolated and cloned a FAAH from rat liver 
plasma membranes [7]. Linoleoyl ethanolamide and linoleoyl 
amide competitively inhibit the hydrolysis of anandamide 
[8,9]. 
It should be noted that anandamide was shown to be con-
verted by mammalian lipoxygenases (LOX) into hydroxy-
anandamide derivatives in vitro [10,11]. Lipoxygenases are 
non-heme iron containing dioxygenases which catalyze the 
conversion of substrates containing one or more 7Z,4Z-pen-
tadiene systems into l-hydroperoxide-2Z,4is-pentadiene deriv-
atives. These hydroperoxides can be toxic for biological sys-
tems. Therefore, the hydroperoxides are readily reduced by 
peroxidases, e.g. glutathione peroxidase [12], to hydroxyl com-
pounds. 12-LOX metabolites, like 12-HETE, have been re-
ported to modulate neurotransmitter activities [13]. Other 
LOX products, like leukotrienes and 15-HETE, have been 
shown to be largely neuroendocrine and vasoactive agents 
[14,15]. 
Hampson et al. demonstrated that 12-hydroxy arachidonyl 
ethanolamide, a brain LOX metabolite from anandamide, is 
capable of binding to the CB-1 receptor even better than 
anandamide [10]. However, 15-hydroxyarachidonyl ethanol-
amide is a much poorer ligand of the CB-1 receptor [10]. In 
contrast, Ueda et al. demonstrated that the 15-hydroxy deriv-
ative inhibits the electrically evoked contraction of mouse vas 
deferens, a typical response of cannabinoids, equally well as 
anandamide, but now the 12-hydroxy product is less effective 
[11]. 
Recently, we have shown that linoleoyl amides can be con-
verted by soybean lipoxy genäse-1 and we have suggested that 
this conversion can be exerted by brain lipoxygenases in vivo. 
[16] However, the physiological significance of the fatty acid 
amide lipoxygenase metabolism remains unclear. An interest-
ing question is whether hydroxylation affects the bioactivities 
of the fatty acid amides. Therefore, we investigated whether 
hydroxylation of linoleoyl amides by the lipoxygenase path-
way influences their binding abilities to the CB-1 receptor and 
whether it alters their reactivity towards a fatty acid amide 
hydrolase. 
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2. Materials and methods Substrate specifity of FAAH 
2.1. Materials 
[3H]CP 55.940 (126 Ci/mmol) was purchased from NEN Dupont 
(Boston, MA, USA). Anandamide was from Matreya Inc. (Pleasant 
Gap, USA) and the other fatty acid amide derivatives were synthe-
sized and purified as described before by Van der Stelt et al. [16]. 
[l-14C]Linoleic acid (55 mCi/mmol) and [l-14C]linoleoyl ethanolamide 
(55 mCi/mmol) were purchased from ARC (St. Louis, MO), USA. 
[l-14C]Arachidonic acid (52 mCi/mmol) was obtained from NEN Du-
Pont. Ethanolamide and NH3 (25%) were from Merck. All other 
reagents used were of the purest grade available. 
The following procedure was used for the synthesis of [1-
14C]anandamide and [l-14C]linoleoyl amide. Dry fatty acid (1 (imol) 
was dissolved in 1 ml dry toluene under nitrogen. To this solution 20 
umol oxalyl chloride was added and the mixture was allowed to react 
for 2 h at 50°C. The reaction mixture was cooled down to room 
temperature and the solvent with the excess of oxalyl chloride was 
evaporated with a nitrogen flow. The residue was dissolved in 0.5 ml 
dry dichloromethane and 10 umol ethanolamine or NH3 (25%) was 
added. After 1 h at room temperature, the residue was dried under a 
nitrogen flow. The products were dissolved in 100 (il methanol and 
subjected to preparative TLC (Silica F254, 0.25 mm; 10X 10 cm). The 
plates were developed in chloroform/methanol/ammonia (25%), 94/6/1 
(v/v) for anandamide and 85/15/1 (v/v) for linoleoyl amide. The spots 
which corresponded to the fatty acid amides were scraped off and 
extracted with 5 ml chloroform. The silica was removed through fil-
tration over cotton wool and the solvent was evaporated; the residue 
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Fig. 2. Substrate specifity (±S.D.) of FAAH from the 11300Xg 
pellet fraction of rat brain. Incubations of 15 min were performed 
as described in Section 2. 
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Fig. 1. Displacement curves of (A) linoleoyl amides (ODNHEtOH, 
ODNH2) and (B) their hydroxylated products (13-HODNHEtOH, 
I3-HODNH2). Error bars represent the S.D. 
was dissolved in 500 u.1 methanol. Purity of the fatty acid amides 
( > 95%) was checked with RP-HPLC as described below. 
The hydroxylation of the [l-14C]fatty acid amides was performed as 
described by Van der Stelt et al. [16]. The dioxygenation reaction was 
led to completion by the addition of an extra 50 nM lipoxygenase-1, 
30 min after the reaction started. Soybean lipoxygenase-1 was purified 
as described by Finazzi Agro [17]. Purity of the reduced products 
( > 95%) was checked with RP-HPLC as described below. 
2.2. Membrane preparation for binding assay 
Male Wistar rats (250-280 g) were maintained on a 12 h light/dark 
schedule, before they were killed. Food and water were ad libitum. 
The experimental protocol and procedures used met the guidelines of 
the Ministry of Health (G.U. No. 40, February 18, 1992) and were 
approved by the Animal Care Committee (University of Rome 'Tor 
Vergata'). 
Membrane preparations were obtained using the method of Devane 
et al. [18] and were stored at a concentration of 1 mg/ml protein in 
buffer A (50 mM Tris-HCl, 2 mM Tris-EDTA, 3 mM MgCl2, pH 7.4) 
at — 80°C for no longer than 1 week. The protein concentration was 
determined according to Bradford [19], using bovine serum albumin 
(BSA) as a standard. 
2.3. Binding assay 
Unless other wise stated, a rapid filtration assay was performed 
with 3H-labeled CP 55.940, according to Compton et al. [20]. Incu-
bations were performed in a final volume of 0.5 ml buffer B (50 mM 
Tris-HCl, 2 mM Tris-EDTA, 3 mM MgCl2, 5 mg/ml BSA, pH 7.4). 
PMSF (final concentration 50 uM) was added fresh each time just 
before the incubations started. The binding was initiated by the addi-
tion of 48 ixg of protein of the membrane preparation and stopped 
after 1 h at 30°C. The washed filters were transferred to vials, which 
contained 0.5 ml 0.1% Triton X-100 and 3.5 ml liquid scintillation 
cocktail (LSC, OpticFluor, Canberra Packard). The vials were incu-
bated overnight before counting. Unspecific binding was determined 
in the presence of 10 uM anandamide. Binding data were analyzed 
with the program GraphPad, which performs weighted non-linear 
least squares curve fitting to the general model of Feldman [21]. 
Data reported in this article are the mean of two independent experi-
ments, each performed in triplicate. 
2.4. Hydrolase assay 
The cortex of one rat was homogenized with an UltraTurrax T 25 
in 12.5 ml buffer C (50 mM Tris-HCl, 1 mM EDTA, pH 7.4). The 
homogenate was centrifuged for 20 min at 11 300 X g. The pellet was 
M. van der Steh et al.lFEBS Letters 415 (1997) 313-316 315 
resuspended in buffer C at a protein concentration of 1 mg/ml and 
stored at -80°C. 
Unless stated otherwise, the incubations were made according to 
Maurelli et al. [8] and Hillard et al. [22]. [l-14C]Fatty acid amide, in a 
final concentration of 3 u,M, was added to a total volume of 0.2 ml 
hydrolase assay buffer D (50 mM Tris-HCl, pH 9.0). The reaction was 
initiated by the addition of 10 |ig protein and incubated for 15 min at 
37°C. The reaction was terminated by the addition of 0.8 ml ice-cold 
methanol/chloroform (2:1, v/v), with vortexing. The radioactive sub-
strates and products were extracted from the mixture according to the 
extraction procedure of Bligh and Dyer [23]. The final residue was 
dissolved in 50 ul methanol and subjected to RP-HPLC analysis, 
using a Perkin Elmer Nelson Model 1022 Plus Chromatograph, 
equipped with a Perkin Elmer series 200 LC Pump and a Canberra 
Packard Flow Scintillation Analyzer 500 TR Series with a 0.5 ml flow 
cell. Absorbance values were recorded at 204 nm. 
The HPLC analysis of the radioactive substrates and products was 
carried out on a C18 (5 |im, 30x3 mm i.d. : SGE) column, using a 
mixture of methanol/water/acetic acid (85/15/0.1, v/v) for the non-
hydroxylated substrates and methanol/tetrahydrofuran/water/acetic 
acid (30/25/45/0.1, v/v) for the hydroxylated substrates as the eluent 
at a flow rate of 0.8 ml/min. LSC (UltimaFlo M, Canberra Packard) 
was mixed with the eluent at a ratio of 1:2 (eluent/LSC). The ratio 
substrate/product was calculated from the peak areas of the chroma-
tograms, assessing peak identity by co-injection of authentic stand-
ards. 
3. Results 
In order to investigate the effect of hydroxylation on the 
bioactivities of hnoleoyl amides, fatty acid amides and their 
hydroxylated derivatives were assessed as ligands to displace 
the potent cannabinoid [3H]CP 55.940 from the CB-1 receptor 
of rat brain. From this radioligand displacement assay it is 
clear that neither the hnoleoyl amides nor their hydroxylated 
products were capable of displacing the radioligand from the 
receptor (Fig. 1 A,B). The KL of all four ligands exceeded 1 U.M, 
being much larger than the K\ of anandamide of 27 ±4 nM. 
To investigate if hydroxylation affects the hydrolysis of li-
noleoyl amide by a FAAH, the l-14C-labeled fatty acid 
amides (3 ¡J.M) and their hydroxylated derivatives (3 |0.M) 
were incubated with rat brain membrane preparation with a 
concentration of 50 ng/ml protein. Interestingly, hydroxyla-
tion slowed down the conversion of ODNHEtOH and 
ODNH2 by FAAH (Fig. 2). The activity of FAAH towards 
the fatty acid amides was measured at several substrate con-
centrations and the obtained data were fitted to the standard 
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Fig. 4. Inhibition of anandamide hydrolysis by rat brain FAAH in 
the presence of Hnoleoyl ethanolamide (ODNHEtOH) and its hy-
droxylated derivative (13-HODNHEtOH). The error bars represent 
the S.D. 
Michaelis-Menten equation, without the use of any graphical 
method such as Lineweaver-Burk (Fig. 3). Rat brain FAAH 
had an equal affinity for the non-hydroxylated substrates 
ODNHEtOH (A™ = 8.0 ±1.0 (S.D.) uM) and ODNH2 
(Am = 8.3 ±1.5 U.M). The maximum hydrolysis rate for 
ODNH2 (Kmax = 3317 ±289 pmol/min/mg protein) was twice 
as high as for ODNHEtOH (Fm a x= 1859 ± 105 pmol/min/mg 
protein). Hydroxylation of the substrates had a different effect 
on each of them. For 13-HODNHEtOH the Km remained of 
the same order of magnitude (Am = 3.9 ±0.8 nM), but the 
maximum reaction rate was reduced to 27% ( Vmsa = 543 ± 25 
pmol/min/mg protein). The affinity of FAAH for 13-
HODNH2 was reduced to 20% (.fi:m = 4 0 ± l l uM), but the 
VmBX (3829 ± 674 pmol/min/mg protein) was unaltered. 
To investigate the effect of hydroxylation on the competi-
tive inhibition of the anandamide hydrolysis by hnoleoyl etha-
nolamide, a 5 u,M solution of [l-14C]anandamide was incu-
bated with 10 u.M ODNHEtOH or 10 uM 13-HODNHEtOH 
and rat brain membrane preparation with a protein concen-
tration of 50 ng/ml (Fig. 4). Interestingly, hydroxylation 
doubled the ability of ODNHEtOH to inhibit anandamide 
hydrolysis. 
4. Discussion 
Fatty acid amides such as Hnoleoyl ethanolamide and hno-
leoyl amide can be hydroxylated by the lipoxygenase pathway 
in vitro [16]. As yet, the physiological significance of this 
metabolic pathway is not established and it is unclear whether 
this hydroxylation alters the bioactivities of the fatty acid 
amides. Therefore, we investigated whether hydroxylation of 
hnoleoyl amides by the lipoxygenase pathway influences their 
binding abilities to the CB-1 receptor and whether it affects 
their reactivity towards a FAAH. 
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Although several extensive structure-activity studies of CB-
1 endo-cannabinoid ligands have been reported [24,25], only 
Sheskin et al. reported a K¡ for ODNHEtOH of >25 uM 
[26]. Our results are consistent with theirs. Hydroxylation of 
the lZ,4Z-pentadiene containing fatty acid amides does not 
result in a more enhanced binding with the CB-1 receptor, as 
observed for the 12-lipoxygenäse product of anandamide [10]. 
At least three double bonds seem necessary for an endo-can-
nabinoid to show any affinity for the CB-1 receptor [26]. 
Therefore, hydroxylation of linoleoyl amides does not directly 
affect the cannabinomimetic properties of these fatty acid 
amides. 
Hydroxylation of ODNHEtOH results in a strong reduc-
tion of the maximum rate of hydrolysis by a FAAH, but the 
affinity of FAAH remains of the same order of magnitude. 
Hydroxylation of ODNH2 leads to a decrease in the affinity of 
FAAH for the substrate, but its maximum conversion rate is 
unaffected. Therefore, the activity of FAAH is reduced at low 
13-HODNH2 concentrations. Furthermore, hydroxylation of 
ODNHEtOH enhances its capacity to competitively inhibit 
the hydrolysis of anandamide. Thus, hydroxylation by the 
lipoxygenase pathway of linoleoyl amides impairs the hydrol-
ysis of fatty acid amides by a FAAH. The resulting prolonged 
the lifetime of anandamide and other fatty acid amide deriv-
atives may thus have a considerable impact on cellular signal 
transduction. 
Dersarnaud et al. observed that replacing eis double bonds 
with trans double bonds reduced the inhibitory effects of fatty 
acid amides on the hydrolysis of [3H]anandamide by rat brain 
microsomes [27]. Therefore, it is reasonable to suggest that the 
enhanced inhibitory effect we observed is mainly due to the 
introduction of the hydroxyl function at the 13-position of the 
fatty acid amide and not to the isomerisation of the two eis 
double bonds into a cis-frvms-conjugated diene. Work is in 
progress to study whether other regio-isomeric lipoxygenase 
products of fatty acid amides exhibit a similar effect. 
In conclusion, this study has shown that hydroxylation of 
linoleoyl amides by the lipoxygenase pathway via dioxygena-
tion, followed by reduction of the hydroperoxides, does not 
alter their binding abilities to the CB-1 receptor. However, 
hydroxylation of lZ,4Z-pentadiene containing fatty acid 
amides can affect their bioactivities by impairing their reac-
tivity towards a fatty acid amide hydrolase. Hence, the pro-
longed lifetime of anandamide and other fatty acid amide 
derivatives can have a considerable impact on cellular signal-
ing. 
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